hopefully current management arent just planting a seed about non-dillutive funding. If grants or partnerships ultimately dont come through and say well we tried but didnt happened so load up instos and s.708 pockets. Raise in US in USD would be warranted, AUD to USD trial to dillutive funding x 1.5.
AML deal seems to be front and centre, with cardio being a slower burn. We are fully funded for this so would just be locking in a deal for venetoclax or decitabine. If partnership is struck how quick will the second trial be dropped?
Also, what Pharma in their right mind would partner for a drug (i.e. RC220) not yet available as cGMP?
Devils advocate, was the strategic update overpromise and underdeliver, or is there actually something of substance. Saying today, tomorrow net week or month, should have been rounded out with trial completion IMO?
Think its all coming together from a charting perspective.
RAC - Charts & Price Action, page-16988
-
- There are more pages in this discussion • 4,602 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |